p27kip1 antisense-induced proliferative activity of rat corneal endothelial cells

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 6, 2004, Pages 1763-1770

  Kikuchi, Michiharu ^a,b   Harris, Deshea L ^a   Obara, Yoshitaka ^b   Senoo, Tadashi ^b   Joyce, Nancy C ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ANTISENSE OLIGONUCLEOTIDE; BROXURIDINE; CELL CYCLE PROTEIN; CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; KI 67 ANTIGEN; LIPID; PROPIDIUM IODIDE; PROTEIN P15; PROTEIN P27; CDKN1B PROTEIN, RAT; CYCLIN DEPENDENT KINASE INHIBITOR 1B; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORNEA ENDOTHELIUM; DOWN REGULATION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL CULTURE; CELL DIVISION; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; GENE TRANSFER; GENETICS; MALE; METABOLISM; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL CYCLE PROTEINS; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; ENDOTHELIUM, CORNEAL; GENE TRANSFER TECHNIQUES; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 3042619133     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0885     Document Type: Article

References (55)

1. Svedbergh B, Bill A. Scanning electron microscopic studies of the corneal endothelium in man and monkeys. Acta Ophthalmol. 1972;50:321-326.
2. Murphy C, Alvarado J, Juster P, Maglio M. Prenatal and postnatal cellularity of the human corneal endothelium: a quantitative histologic study. Invest Ophthalmol Vis Sci. 1984;25:312-322.
3. Laing RA, Sandstrom MM, Berrospi AR, Leibowitz HM. Changes in the corneal endothelium as a function of age. Exp Eye Res. 1976; 22:587-594.
4. Schultz RO, Matsuda M, Yee RW, Edelhauser HF. Corneal endothelial changes in type I and type II diabetes mellitus. Am J Ophthalmol. 1984;98:401-410.
5. Gagnon MM, Boisjoly HM, Brunette I, Charest M, Amyot M. Corneal endothelial cell density in glaucoma. Cornea. 1997;16:314-318.
6. Rao GN, Shaw EL, Arthur E, Aquavella JV. Morphologic appearance of the healing corneal endothelium. Arch Ophthalmol. 1978;96: 2027-2030.
7. Brooks AM, Gilles WE. Effect of angle closure glaucoma and surgical intervention on the corneal endothelium. Cornea. 1991; 10:489-497.
8. Bergmann L, Hartmann C, Renard G, Saragoussi JJ, Pouliquen Y. Damage to the corneal endothelium caused by radial keratotomy. Fortschr Ophthalmol. 1991;88:368-373.
9. Laing RA, Neubauer L, Oak S, Kayne HL, Leibowitz HM. Evidence for mitosis in adult corneal endothelium. Ophthalmology. 1984; 91:1129-1134.
10. Joyce NC, Meklir B, Joyce SJ, Zieske JD. Cell cycle protein expression and proliferative status in human corneal cells. Invest Ophthalmol Vis Sci. 1996;37:645-755.
11. Joyce NC, Navon SE, Roy S, Zieske JD. Expression of cell cycle-associated proteins in human and rabbit corneal endothelium in situ. Invest Ophthalmol Vis Sci. 1996;37:1566-1575.
12. Sherr CJ. Mammalian G1 cyclins. Cell. 1993;73:1059-1065.
13. Kato J, Matsushima H, Hiebert SW, et al. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 1993;7: 331-342.
14. Leone G, DeGregori J, Jakoi L, et al. Collaborative role of E2F transcriptional activity and G1 cyclin dependent kinase activity in the induction of S phase. Proc Natl Acad Sci USA. 1999;96:6626-6632.
15. Ewen ME, Sluss HK, Sherr CJ, et al. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell. 1993; 73:487-497.
16. Coverley D, Laman H, Laskey RA. Distinct roles for cyclins E and A during DNA replication complex assembly and activation. Nat Cell Biol. 2002;4:523-528.
17. Draviam VM, Orrechia S, Lowe M, et al. The localization of human cyclins B1 and B2 determines CDK1 substrate specificity and neither enzyme requires MEK to disassemble the Golgi apparatus. J Cell Biol. 2001;152:945-958.
18. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366:704-707.
19. Hannon GJ, Beach D. p 15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 1994;371:257-261.
20. Guan KL, Jenkins CW, Li Y, et al. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 1994;8:2939-2952.
21. Chan FK, Zhang J, Cheng L, Shapiro DN, Winoto A. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4. Mol Cell Biol. 1995;15:2682-2688.
22. Jeffrey PD, Tong L, Pavletich NP. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev. 2000;14: 3115-3125.
23. Reynisdottir I, Polyak K, Iavarone A, Massague J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 1995;9:1831-1845.
24. Harper JW, Adamin GF, Wei N, et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993;75:805-816.
25. Polyak K, Lee MH, Erdjument-Breomage H, et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 1994;78:56-66.
26. Lee MH, Reynisdottir I, Massague J. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 1995;9:639-649.
27. Dulic V, Stein GH, Far DF, Reed SI. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol Cell Biol. 1998;18:546-557.
28. Polyak K, Kato JY, Solomon MJ, et al. p27Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 1994;8:9-22.
29. Levenberg S, Yarden A, Kam Z, Geiger B. p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entry. Oncogene. 1999;18:869-876.
30. Bae I, Fan S, Bhatia K, et al. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells. Cancer Res. 1995;55:2387-2393.
31. Chen J, Willingham T, Shuford M, Nisen PD. Tumor suppression and inhibition of aneuploid cell accumulation in human brain tumor cells by ectopic overexpression of the cyclin-dependent kinase inhibitor p27kip1. J Clin Invest. 1996;97:1983-1988.
32. Nakayama K, Ishida N, Shirane M, et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 1996;85:707-720.
33. Joyce NC, Harris DL, Mello DM. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-β2. Invest Ophthalmol Vis Sci. 2002;43:2152-2159.
34. Kip1 play a role in PLC-γ1-mediated mitogenic signaling pathway of 18 kDa FGF-2 in corneal endothetial cells. Mol Vis. 2002;8:17-25.
35. Lee HT, Kay EDP. Regulatory role of PI 3-kinase on expression of Cdk4 and p27, nuclear localization of Cdk4, and phosphorylation of p27 in corneal endothelial cells. Invest Ophthalmol Vis Sci. 2003;44:1521-1528.
36. Kip1 in cAMP- and TGF-β2-mediated antiproliferation in rabbit corneal endothelial cells. Invest Ophthalmol Vis Sci. 2001;42:3142-3149.
37. Rivard N, L'Allemain G, Bartek J, Pouyssegur J. Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (GO state) in fibroblasts. J Biol Chem. 1996;271:18337-18341.
38. Graham M, Rawe I, Dartt D, Joyce NC. Protein kinase C regulation of corneal endothelial cell proliferation and cell cycle. Invest Ophthalmol Vis Sci. 2000;41:4124-4132.
39. Crooke ST. Progress in antisense therapeutics. Med Res Rev. 1996; 16:319-344.
40. Phillips MI. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension. 1997;29:177-187.
41. Turner C. Antisense therapy: therapeutic magic bullet or theoretical dream. Clin Oncol. 1997;9:54-61.
42. Chen KH, Harris DL, Joyce NC. TGF-beta2 in aqueous humor suppresses S-phase entry in cultured corneal endothelial cells. Invest Ophthalmol Vis Sci. 1999;40:2513-2519.
43. St Croix B, Florenes VA, Rak JW, et al. Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents. Nat Med. 1996;2:1204-1210.
44. Gerdes J, Li L, Schluter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol. 1991;38:867-873.
45. Verheijen R, Kuijpers HJH, Driel R, et al. Ki-67 detects a nuclear matrix-associated proliferation-related antigen: localization in mitotic cells and association with chromosomes. J Cell Sci. 1989;92: 531-540.
46. Kill IR, Faragher RG, Lawrence K, Shall S. The expression of proliferation-dependent antigens during the lifespan of normal and progeroid human fibroblasts in culture. J Cell Sci. 1994;107:571-579.
47. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363-9367.
48. Senoo T, Joyce NC. Cell cycle kinetics in corneal endothelium from old and young donors. Invest Ophthalmol Vis Sci. 2000;41: 660-667.
49. Senoo T, Obara, Y, Joyce NC. EDTA: promoter of proliferation in human corneal endothelium. Invest Ophthalmol Vis Sci. 2000;41: 2930-2935.
50. Kay EP, Gu X, Smith RE. Corneal endothelial modulation: bFGF as direct mediator and corneal endothelium modulation factor as inducer. Invest Ophthalmol Vis Sci. 1994;35:2427-2435.
51. Peng HS, Livanov V, Zhang W, Li J, Lesher T. Modification of phosphorothioate oligonucleotides yields potent analogs with minimal toxicity for antisense experiments in the CNS. Mol Brain Res. 1998;62:1-11.
52. Suzuki S, Pilowsky P, Minson J, Arnolda L, Llewellyn-Smith IJ, Chalmers J. c-fos antisense in rostral ventral medulla reduces arterial blood pressure. Am J Physiol. 1994;266:1418-1422.
53. Morimoto S, Sasaki S, Miki S, et al. Pressor response to pulsatile compression of the rostral ventrolateral medulla mediated by nitric oxide and c-fos expression. Br J Pharmacol. 2000;129:859-864.
54. Hall M, Bates S, Peters G. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene. 1995;11:1581-1588.
55. Pardee AB. G1 events and regulation of cell proliferation. Science. 1989;246:603-608.